Clinicopathological significance of BRCAness in resectable pancreatic ductal adenocarcinoma and its association with anticancer drug sensitivity in pancreatic cancer cells

被引:0
|
作者
Tadehara, Masayoshi [1 ]
Kato, Takuya [1 ]
Adachi, Kai [1 ]
Sakurai, Yasutaka [1 ]
Ichinoe, Masaaki [1 ]
Murakumo, Yoshiki [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Path, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P14-10-3
引用
收藏
页码:440 / 440
页数:1
相关论文
共 50 条
  • [1] Clinicopathological Significance of BRCAness in Resectable Pancreatic Ductal Adenocarcinoma and Its Association With Anticancer Drug Sensitivity in Pancreatic Cancer Cells
    Tadehara, Masayoshi
    Kato, Takuya
    Adachi, Kai
    Tamaki, Akihiro
    Kesen, Yurika
    Sakurai, Yasutaka
    Ichinoe, Masaaki
    Koizumi, Wasaburo
    Murakumo, Yoshiki
    [J]. PANCREAS, 2022, 51 (02) : 183 - 189
  • [2] Analysis of clinical significance of BRCAness in pancreatic ductal adenocarcinoma
    Tadehara, Masayoshi
    Kato, Takuya
    Adachi, Kai
    Sakurai, Yasutaka
    Ichinoe, Masaaki
    Murakumo, Yoshiki
    [J]. CANCER SCIENCE, 2021, 112 : 810 - 810
  • [3] The prognostic significance of PDGFβR in pancreatic ductal adenocarcinoma and its association with cancer stem cells
    Strell, Carina
    Paulsson, Janna
    Johansen, Julia S.
    Heuchel, Rainer
    Schultz, Nicolai A.
    Egevad, Lars
    Lohr, Matthias
    Ostman, Arne
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 175 - 175
  • [4] Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma
    Lu, Jun
    Zhou, Li
    Yang, Gang
    Liang, Zhi-Yong
    Zhou, Wei-Xun
    You, Lei
    Yuan, Da
    Li, Bing-Qi
    Guo, Jun-Chao
    Zhao, Yu-Pei
    [J]. HUMAN PATHOLOGY, 2019, 86 : 143 - 154
  • [5] Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
    Chen, Ru
    Pan, Sheng
    Maitra, Anirban
    Simeone, Diane
    Dawson, David
    Brentnall, Teresa
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [6] Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma
    Chen, Ru
    Dawson, David W.
    Pan, Sheng
    Ottenhof, Niki A.
    De Wilde, Roeland F.
    Wolfgang, Christopher L.
    May, Damon H.
    Crispin, David A.
    Lai, Lisa A.
    Lay, Anna R.
    Waghray, Meghna
    Wang, Shouli
    McIntosh, Martin W.
    Simeone, Diane M.
    Maitra, Anirban
    Brentnall, Teresa A.
    [J]. LABORATORY INVESTIGATION, 2015, 95 (01) : 43 - 55
  • [7] Clinicopathological and genetic prognostic factors in patients with surgically resectable pancreatic ductal adenocarcinoma
    Gall, Tamara
    Frampton, Adam
    Jiao, Long
    [J]. BRITISH JOURNAL OF SURGERY, 2016, 103 : 38 - 38
  • [8] Expression of the adipocytokine resistin and its association with the clinicopathological features and prognosis of pancreatic ductal adenocarcinoma
    Jiang, Chong-Yi
    Wang, Wei
    Yin, Yu-Lei
    Yuan, Zu-Rong
    Wang, Liu-Bo
    [J]. ONCOLOGY LETTERS, 2012, 4 (05) : 960 - 964
  • [9] Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma
    Kawanishi, Aya
    Hirabayashi, Kenichi
    Yamada, Misuzu
    Takanashi, Yumi
    Hadano, Atsuko
    Kawaguchi, Yoshiaki
    Nakagohri, Toshio
    Nakamura, Naoya
    Mine, Tetsuya
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (07) : 619 - 624
  • [10] Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
    Matsushita, Katsunori
    Kobayashi, Shogo
    Akita, Hirofumi
    Konno, Masamitsu
    Asai, Ayumu
    Noda, Takehiro
    Iwagami, Yoshifumi
    Asaoka, Tadafumi
    Gotoh, Kunihito
    Mori, Masaki
    Doki, Yuichiro
    Eguchi, Hidetoshi
    Ishii, Hideshi
    [J]. CANCER REPORTS, 2022, 5 (10)